Evaluation and Treatment of Patients With Dermatologic Diseases

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2014 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00001506
First received: November 3, 1999
Last updated: June 17, 2014
Last verified: February 2014
  Purpose

This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients' diagnosis, response to treatment, and/or disease progression.


Condition
Connective Tissue Disease
Skin Disease

Study Type: Observational
Official Title: Evaluation and Treatment of Subjects With Dermatologic Diseases

Resource links provided by NLM:


Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 500
Study Start Date: June 1996
Detailed Description:

Background

This is a training, natural history of disease, and screening protocol for the evaluation, treatment and follow-up of patients with dermatologic diseases and systemic diseases with cutaneous manifestations. This protocol was developed to allow subject enrollment for teaching purposes and to allow for second opinions regarding relatively complicated patients. The latter function promotes a critical link between the NCI, CCR Dermatology Branch and the local and national extramural medical communities.

Objective

Primary:

- To provide clinical material to fulfill the educational mission of the

Dermatology Branch.

- To learn about the natural history of selected dermatologic diseases.

Secondary:

  • To screen patients for inclusion in other protocols.
  • To assist in the diagnosis and/or management of patients with rare skin diseases and congenital or genetically linked skin conditions.

Eligibility

All subjects regardless of age, gender, or racial/ethnic group with dermatologic disease or systemic disease with cutaneous manifestations.

Design

Patients enrolled in this protocol will be evaluated and treated according to generally available, standard procedures and therapeutic modalities. Samples of blood and skin will be studied by routine and specialized investigative methods to establish these patients diagnosis, response to treatment, and/or disease progression.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Patients of any age, of both genders, and all racial/ethnic groups with dermatologic diseases or systemic diseases with cutaneous manifestations.

Women of childbearing potential, or who are pregnant or lactating, will only undergo tests and procedures, and/or receive medications for which data exists proving minimal risk to the fetus and/or child. Only tests that are clinically indicated for diagnosis will be performed.

Patients must be referred by a physician.

EXCLUSION CRITERIA:

Patients with cognitive impairment.

Pregnancy or lactation, if this status precludes proposed diagnostic procedures or therapies because of known untoward effects on mother and/or child.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00001506

Contacts
Contact: Sharon Osgood, R.N. (301) 443-2163 so140o@nih.gov
Contact: Mark C Udey, M.D. (301) 496-2481 udey@helix.nih.gov

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937      
Contact: Irene Ekwede, B.S.N.    (301) 402-6225    irene.ekwede@nih.gov   
Sponsors and Collaborators
Investigators
Principal Investigator: Mark C Udey, M.D. National Cancer Institute (NCI)
  More Information

Additional Information:
Publications:
ClinicalTrials.gov Identifier: NCT00001506     History of Changes
Obsolete Identifiers: NCT00019149
Other Study ID Numbers: 960102, 96-C-0102
Study First Received: November 3, 1999
Last Updated: June 17, 2014
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Training Protocol
Natural History
Consultation
Standard Therapy
Standard Tests
Training

Additional relevant MeSH terms:
Connective Tissue Diseases
Skin Diseases

ClinicalTrials.gov processed this record on July 26, 2014